Search results
Flu Vaccines: Take a Tour. Take a look at photos of our vaccine teams at work. Protecting Heart Health: Flu vaccines and beyond. Discover how we seek to protect every kind of heart. Read more. Flu is unpredictable. How managing COVID-19 has made predicting influenza even more complex. Read the article. Explore More. Why Vaccines Matter. See more.
- Sanofi: Positive results from the first study of high-dose influenza ...
This high dose influenza vaccine is the first and only...
- Sanofi: Positive results from the first study of high-dose influenza ...
Sanofi offers a range of quadrivalent flu vaccines that help provide active immunization to prevent disease caused by influenza A subtype & type B viruses. Please see Important Safety Information or Prescribing Information.
Fluzone Quadrivalent is a vaccine indicated for active immunization for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine. Fluzone Quadrivalent is approved for use in persons 6 months of age and older. 1
Learn about the Fluzone High-Dose Quadrivalent vaccine indicated for prevention of influenza with 4X more antigen than a standard-dose influenza vaccine. Please see Important Safety Information or Prescribing Information.
Jul 1, 2022 · BRIDGEWATER, N.J., July 1, 2022 /PRNewswire/ -- Today the US Food and Drug Administration (FDA) approved Sanofi's licensure request for vaccine approval for the upcoming 2022-2023 flu season, including: Fluzone High-Dose Quadrivalent (Influenza Vaccine), Flublok Quadrivalent (Influenza Vaccine) and Fluzone Quadrivalent (Influenza Vaccine). 5 ...
Jul 1, 2022 · With protection against four flu strains, Fluzone High-Dose is the only influenza vaccine licensed for use in adults 65 years of age and older to have demonstrated superior efficacy in a...
Oct 7, 2005 · This high dose influenza vaccine is the first and only influenza vaccine proven superior to standard-dose influenza vaccine for the prevention of influenza in adults 65 years of age and older 11, 12, who are a major at-risk group for severe COVID-19 and influenza.
